Beijing Jinhao Pharmaceutical’s real-time fluorescent quantitative PCR analyzer has obtained a Class III medical device registration certificate.
发布时间：2022.10.25
Beijing Jinhao Pharmaceutical Co., Ltd. (hereinafter referred to as “Jinhao Pharmaceutical”) has successfully obtained the Class III medical device product registration certificate from the National Medical Products Administration (NMPA), with registration number Guoxie Zhuzhun 20223221369, for its real-time fluorescent quantitative PCR analyzer. After four years of meticulous development, the time has come to unveil this cutting-edge instrument!
In recent years, driven by the COVID‑19 pandemic, molecular diagnostic technologies—particularly nucleic acid testing—have seen rapid adoption. The real-time fluorescent quantitative PCR analyzer recently certified by Jinhao Pharmaceutical serves as a key instrument platform within the company’s PCR product portfolio, integrating a high‑quality temperature‑control module and a high‑performance optical system. It offers advantages such as fast assay turnaround, a high degree of automation, and user‑friendly operation. Moreover, this product is available in multiple models, catering to diverse qPCR application needs across various settings and supporting the broader deployment and advancement of molecular diagnostics in clinical testing, research services, and other fields.
Follow us
Phone: 400-650-6787 | 010-67878866 | Address: Building 1, No. 7 Yuncheng Street, Beijing Economic-Technological Development Area, Beijing |
© 2026 Beijing Jinhao Pharmaceutical Co., Ltd. All rights reserved | Beijing ICP Filing No. 17020135-2